Well-known versus “unknown” Gamma-Glutamyltransferase and metabolic risk factors for cardiovascular disease: is it just the liver?
Close
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
792 9
Ultima descărcare din IBN:
2023-09-20 15:44
SM ISO690:2012
PELTEC, Angela. Well-known versus “unknown” Gamma-Glutamyltransferase and metabolic risk factors for cardiovascular disease: is it just the liver? In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2011, nr. 3(31), pp. 345-347. ISSN 1857-0011.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale
Numărul 3(31) / 2011 / ISSN 1857-0011

Well-known versus “unknown” Gamma-Glutamyltransferase and metabolic risk factors for cardiovascular disease: is it just the liver?

Pag. 345-347

Peltec Angela
 
Timofei Moșneaga Republican Clinical Hospital
 
 
Disponibil în IBN: 16 decembrie 2013


Rezumat

Gamma-glutamyltransferase is an established liver function test and a sensitive marker of hepatic inflammation. Recent studies have focused increasing attention on the usefulness of GGT as a predictor of cardiovascular disease. As a result, identifying higher than expected GGT levels should alert the physician to study patients more detailed, with the hopeful outcome of preventing unnecessary cardiac-related events and deaths in future years.

Gamma-glutamiltransferaza (GGT) se consideră ca un test funcţional hepatic şi marker sensibil al infl amaţiei hepatice. Studiile recente au atenţionat privind utilitatea GGT ca fi ind factor predicator al patologiei cardiovasculare. Determinarea nivelului ridicat al GGT impune studierea detailată a pacientului cu scopul prevenirii evenimentelor cardiovasculare şi mortalităţii în anii succesivi.

Гамма-глутамилтрансфераза (ГГТ) является при- знанным печёночным тестом и чувствительным маркером печеночного воспаления. В последних ис- следованиях все большее внимание было сосредото- чено на использовании ГГТ как предиктора сердечно- сосудистых заболеваний. Таким образом, определение повышенного уровня ГГТ должно побудить врача для детального исследования пациента с целью предотвра- щения развития сердечно-сосудистых осложнений и смерти в последующие годы.